A second AI does not provide independent confirmation merely because it is a different model. Jev needs evaluation against evidence and appropriate reference judgements, just as the LLM it checks does. Agreement can be useful, but agreement on the same mistaken interpretation is not an additional layer of truth.
A September 2026 preprint makes this problem concrete without establishing that every model combination will fail. This article is published by iatroX, whose own reference and learning systems are included in the discussion of evaluation responsibilities. The same scrutiny should apply to iatroX as to its competitors.
What the new study tested
The 24 September 2026 preprint by Delip Rao and Chris Callison-Burch compared Jev with three flash-tier LLM rubric judges across nine panels from seven benchmarks, including HealthBench. The judges assessed outputs against criteria; this was not a prospective patient-care trial.
Under the tested configuration, the LLM judges were called once per criterion while Jev could batch a unit's criteria. Across the panels, the LLM runs cost 29 to 325 times as much and took 30 to 220 times as long, according to the 24 September 2026 preprint. Accuracy comparisons were often inconclusive, which is not proof of equivalence. The study also found shared departures from reference labels and LLM repetition of confident Jev mistakes. Retrospective cascade evaluation therefore produced limited accuracy gains despite cost savings.
That evidence supports investigating efficient evaluation and correlated errors. It does not establish diagnostic accuracy, patient-outcome improvement or a universal ranking of clinical products. The findings are from a preprint and the configuration it describes, not a fresh experiment conducted for this article.
Why cheaper evaluation is still interesting
A proposed clinical-reference service might currently review only a subset of answer claims because each additional check consumes resources. A less expensive bounded checker could make more frequent checking feasible, provided its limitations are understood.
The strategic opportunity would be to spend some of the saving on better reference material, reviewer time or analysis of difficult cases. It would not automatically follow that the service should remove human review.
A larger number of checks is valuable only when the checks add useful information. Repeating a weak judgement cheaply can increase the appearance of assurance without increasing the likelihood that an important error is detected.
This is an implementation inference, not a cost saving measured in a healthcare deployment. The TypeSafe documentation reviewed on 29 September 2026 offers a way to decompose decisions; a clinical team must still determine whether each proposed check deserves a place in its workflow.
A fictional example of shared error
Imagine a training answer explaining a service's follow-up arrangements. The supplied source says that a specialist team will contact the patient after a pending review. A generated answer instead states that the GP should arrange the next appointment.
Now suppose both the original answer generator and its checker receive a shortened passage that omits the sentence allocating responsibility. Both may find the GP-led interpretation plausible. Their agreement would not recover the missing sentence.
This is a synthetic scenario, not a recorded Jev mistake. It shows one possible route to correlated error: both systems work from the same incomplete evidence. Other possibilities include an ambiguous criterion or an unstated convention in the expected answer. Those possibilities should be investigated rather than asserted as the cause of any particular study result.
The relevant question is not how many models agree. It is what information or method makes the check capable of finding an error the first system could not see.
Two different meanings of a second check
The following textual diagram contrasts proposed evaluation designs. It is not a description of an existing product or a report of measured performance.
Agreement-only design:
Shared shortened passage -> Model A verdict
Shared shortened passage -> Model B verdict
Matching verdicts -> Agreement recorded
Evidence-based review design:
Original source and scope -> Independent reference judgement
Draft claim and cited passage -> Bounded model check
Disagreement or consequential claim -> Clinical adjudication
Reviewed evidence and decision -> Auditable outcome
The second design is not infallible. Its advantage as a proposal is that the reference process can examine information and criteria beyond the two model verdicts. It also preserves disagreement instead of using a vote to make uncertainty disappear.
Independence should be described precisely. A different vendor, model family or prompt is a change in configuration. It is not proof that the new checker has an independent information source or different failure pattern.
Why escalation needs its own evidence
TypeSafe's confidence-routing pattern, checked on 29 September 2026, illustrates sending different decisions down different routes. For healthcare, routing an uncertain judgement to another AI would be a proposed policy requiring evaluation, not an assurance in itself.
A useful local test would ask which errors the fallback actually corrects. It should distinguish cases where the first model is uncertain from cases where it is confidently wrong. A fallback that only sees uncertainty may never encounter the most convincing mistakes.
The test should also compare the combined workflow with the strongest single candidate under the same conditions. Adding another stage can increase complexity, latency and monitoring requirements. Those costs need justification through improved outcomes or a clearly acceptable efficiency trade-off.
Where clinical evidence is missing, escalation may need to mean obtaining the source or consulting an appropriate person, rather than asking a larger model to make the same judgement again.
How to test the checker without hiding difficult cases
A proposed evaluation set should include supported claims, subtle overstatements, contradictions and cases where the supplied passage is insufficient. Clinicians should adjudicate the reference outcome with access to the necessary context and record unresolved disagreement.
Do not review only the cases flagged by the model. Include a sample of apparently straightforward accepted outputs, especially those that could produce consequential actions. Otherwise the evaluation may confirm that the review queue contains uncertainty while overlooking false reassurance outside it.
The reference team should inspect both the decision and its downstream use. A false positive in an exploratory search filter may have a different consequence from the same label closing a follow-up task.
Record the actual model version, rubric wording, source snapshot and routing policy. A later improvement in average agreement should not conceal a new pattern of confident mistakes in an important document type.
These are proposed study requirements. No local clinical checking study was performed here, and no fabricated improvement percentage is offered.
The verdict for developers, clinicians and buyers
For developers running large volumes of bounded evaluation, Jev is a plausible candidate to test on cost and task performance. For clinicians interpreting an "AI checked" label, the useful question is what evidence was checked and how disagreement was handled.
For buyers, a multi-model diagram is not sufficient assurance. Request the observed error patterns of the assembled workflow, including cases where the models agree and the reference judgement does not.
For iatroX and other clinical platforms, publishing a methodology is a starting point for scrutiny, not a reason to stop asking these questions. More affordable checking could improve a service, but only if the service knows what its checkers can miss.
Frequently asked questions
Can one AI reliably check another?
It can contribute to a defined checking task after evaluation. Reliability cannot be inferred simply from using a second model or obtaining matching answers.
What are correlated errors?
They are errors that occur together more often than an independence assumption would predict. Shared inputs or interpretation problems are possible explanations, but the cause needs investigation.
Does model agreement mean an answer is safe?
No. Agreement establishes consistency between the compared outputs, not clinical appropriateness or completeness of the evidence.